Bristol-Myers Squibb selects Dendrite for strategic sales and marketing initiative



Under the terms of the agreement, Dendrite will provide licenses and services for it's WebForce solution with embedded Force Analyzer, training and technical support services. In addition, the implementation by Dendrite will integrate a national express tracking system as well as an enhanced sample management system into the WebForce offering.

Bristol-Myers Squibb Company has selected Dendrite after a thorough evaluation of alternative suppliers available in the market, said John Bailye, Chairman and CEO, Dendrite International. This agreement reinforces Dendrite's commitment to build vertically integrated systems that comprehensively address several sales force-related issues.